Kaposi's sarcoma-associated herpes virus (KSHV) contributes to the pathogenesis of
Kaposi's sarcoma and
primary effusion lymphomas. KSHV encodes a
G protein-coupled receptor (
KSHV-GPCR) that signals constitutively and transforms NIH3T3 cells. Here, we show that
KSHV-GPCR transformation requires activation of the
small G protein Rac1 and its effector, the
p21-activated kinase 1 (Pak1). Either transient or sustained expression of
KSHV-GPCR activated both Rac1 and Pak1. Furthermore, expression of dominant-negative mutants of Rac (RacN17) or Pak1 (PakR299, Pak-PID) inhibited
KSHV-GPCR-induced focus formation and growth in soft
agar. We also demonstrate that signaling from Pak1 to
nuclear factor-kappaB (NFkappaB) is required for cell transformation induced by
KSHV-GPCR.
KSHV-GPCR induced transcriptional activation by NFkappaB. This process is inhibited by the PAK-PID, whereas reciprocally, expression of constitutively active Pak1 (PakL107F) activated NFkappaB comparably to
KSHV-GPCR. The Pak-PID and RacN17 inhibited the
KSHV-GPCR-induced phosphorylation of inhibitor of kappaB
kinase-beta and inhibitor of kappaB-alpha, implying that it is Pak1-dependent phosphorylation and subsequent destruction of the inhibitor of kappaB
proteins that allows NFkappaB activation. Finally, experiments with the
KSHV-GPCR inverse agonist
interferon-gamma-inducible protein-10, the Galpha(i) inhibitor
pertussis toxin, and an inhibitor of
phosphatidylinositol 3'-kinase,
wortmannin, indicate that signaling through the Galpha(i) pathway and
phosphatidylinositol 3'-kinase contributes to the cell transformation and NFkappaB activation induced by the
KSHV-GPCR.